Freeport, Bahamas - The Regenera Global conference is coming to Freeport and will take place at the Grand Lucayan Resort from June 23-25, 2016. Grand Bahama based cell therapy facility, Okyanos has announced they are platinum sponsors of the event and will be hosting a Cell Therapy Surgical Center Tour and Networking Reception event as part of the conference agenda.
Regenerative Medicine 2.0: Redefining the Practice, the conference will bring together scientists, clinicians, patients, medical device manufacturers and industry stakeholders in the field of stem cell-based therapies to discuss the transition of evidence-based science to accessible treatments in a clinical setting. Keynote speakers will include Doris Taylor, PhD, Director of Regenerative Medicine Research at Texas Heart Institute; as well as Leslie Miller, MD, Director of Heart Failure and Stem Cell Research at Baycare Health.
“We are excited to welcome Okyanos Cell Therapy as a partner in uniting global regenerative medicine thought leaders for this meeting,” said Luis Martinez, MD, CEO of Regenera Global, Inc. “With gene and stem cell therapy research and clinical applications ongoing it is clear this field is progressing rapidly. This is an opportune time for experts from various disciplines to gather and discuss groundbreaking advances as well as the safest and most effective ways to bring these treatments to patients.”
“We are pleased to support this relevant and timely conference as it plays an important role in redefining the future of cell therapy as a standard of care,” added Matthew Feshbach, CEO of Okyanos. “We have dedicated tremendous effort and resources to bringing stem cell therapy to our patients at the highest possible standards of safety, delivery and care. Our team is proud and excited to share these insights with industry leaders in June.”
Operating in Freeport, Grand Bahama, Okyanos Cell Therapy began treating patients in 2014. The procedure is premised on the reparative power of adult stem cells isolated from the patient’s body fat which have the potential to decrease inflammation, repair damaged tissue, modulate immune response and stimulate new blood vessel growth, and thus address a variety of chronic, degenerative diseases.
Other prominent speakers will include Amit Patel, MD, Director of Clinical Regenerative Medicine and Tissue Engineering at the University of Utah, and Frances Verter, PhD, Founder of the Parent’s Guide to Cord Blood Foundation. To learn more about the Regenera Global conference agenda or to register, please visit www.regeneraglobal.com.
About Regenera Global
Regenera Global was founded on three main
principles: Innovation, Inter-global communication, and Intention
towards addressing unmet needs in Regenerative Medicine. While the field
is experiencing much growth, there is still a need to bridge the gap
between the current progress in research and what is available
clinically. Additionally, the asynchronous and, at times, geographically
incommunicable developments of novel therapies makes patients and
physicians unaware of their global availability. With this in mind, and
understanding that there is still much room for innovation and out of
the box thinking, Regenera Global was born.
We strive to build
bridges. To innovate in research so as to better understand how our
cells regenerate. To educate physicians on the latest advancements and
practices in stem cells, gene therapy and tissue engineering. To connect
patients with the novel therapies that they need. To develop a network
through which clinics, laboratories, and policy makers function as one.